Evaluation of Minimal Residual Disease Using Next Generation Flow Cytometry in Patients With AL Amyloidosis

Autor:	Theodorakakou, Foteini 1, Fotiou, Despina 1, Kostopoulos, Ioannis 2, Terpos, Evangelos 1, Gavriatopoulou, Maria 1, Spiliopoulou, Vasiliki 1, Ntanasis-Stathopoulos, Ioannis 1, Malandrakis, Panagiotis 1, Kanellias, Nikolaos 1, Roussou, Maria 1, Migkou, Magdalini 1, Eleutherakis-Papaiakovou, Evangelos 1, Solia, Eirini 1, Papathoma, Alexandra 1, Tsitsiloni, Ourania 2, Dimopoulos, Meletios-Athanasios 1, Kastritis, Efstathios 1
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S245-S245
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect